TTNP Titan Pharmaceuticals Inc.

1.55
+0.01  (+1%)
Previous Close 1.54
Open 1.52
Price To Book 6.74
Market Cap 20,940,181
Shares 13,509,794
Volume 8,529
Short Ratio
Av. Daily Volume 276,475

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 treatment has commenced - noted October 11, 2017. DSMB recommended trial to continue - July 2, 2018 but further enrollment has been postponed due to lack of resources.
Ropinirole implant
Parkinson's disease
CRL issued April 30, 2013. Approved May 26 2016
Probuphine
Opioid dependence

Latest News

  1. Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®
  2. TTNP: A+ Partnerships: AllianceRx, AppianRx & Accredo
  3. Edited Transcript of TTNP earnings conference call or presentation 15-May-19 8:30pm GMT
  4. Titan Pharmaceuticals: 1Q Earnings Snapshot
  5. Titan Pharmaceuticals Reports First Quarter 2019 Financial Results
  6. Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®
  7. Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow
  8. Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT
  9. Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®
  10. Knight Therapeutics: Use of PROBUPHINE™ for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
  11. TTNP: EMA Approval of Probuphine Expected 2Q:19
  12. Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
  13. Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services
  14. Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019
  15. 4 Healthcare Stocks Looking To Kick Off A Strong Week
  16. Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®
  17. TTNP: Shipments Spike in 2H:18
  18. 4 Healthcare Stocks Looking To Start February Off Strong
  19. Why Titan Pharmaceuticals Is Soaring Today